Cargando…
Current Status of Oligonucleotide-Based Protein Degraders
Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfacto...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055846/ https://www.ncbi.nlm.nih.gov/pubmed/36986626 http://dx.doi.org/10.3390/pharmaceutics15030765 |
_version_ | 1785015974457507840 |
---|---|
author | Shih, Po-Chang Naganuma, Miyako Demizu, Yosuke Naito, Mikihiko |
author_facet | Shih, Po-Chang Naganuma, Miyako Demizu, Yosuke Naito, Mikihiko |
author_sort | Shih, Po-Chang |
collection | PubMed |
description | Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders. |
format | Online Article Text |
id | pubmed-10055846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100558462023-03-30 Current Status of Oligonucleotide-Based Protein Degraders Shih, Po-Chang Naganuma, Miyako Demizu, Yosuke Naito, Mikihiko Pharmaceutics Review Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders. MDPI 2023-02-24 /pmc/articles/PMC10055846/ /pubmed/36986626 http://dx.doi.org/10.3390/pharmaceutics15030765 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Shih, Po-Chang Naganuma, Miyako Demizu, Yosuke Naito, Mikihiko Current Status of Oligonucleotide-Based Protein Degraders |
title | Current Status of Oligonucleotide-Based Protein Degraders |
title_full | Current Status of Oligonucleotide-Based Protein Degraders |
title_fullStr | Current Status of Oligonucleotide-Based Protein Degraders |
title_full_unstemmed | Current Status of Oligonucleotide-Based Protein Degraders |
title_short | Current Status of Oligonucleotide-Based Protein Degraders |
title_sort | current status of oligonucleotide-based protein degraders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055846/ https://www.ncbi.nlm.nih.gov/pubmed/36986626 http://dx.doi.org/10.3390/pharmaceutics15030765 |
work_keys_str_mv | AT shihpochang currentstatusofoligonucleotidebasedproteindegraders AT naganumamiyako currentstatusofoligonucleotidebasedproteindegraders AT demizuyosuke currentstatusofoligonucleotidebasedproteindegraders AT naitomikihiko currentstatusofoligonucleotidebasedproteindegraders |